MedTrace Logo

Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

NCT05700916 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2025-12-22

No results posted yet for this study

Summary

The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.

Conditions

Interventions

DRUG

Milk Polar Lipid-Rich Dairy Powder

Effects of the addition of 6.5 g of milk polar lipids to dairy powder.

DIETARY_SUPPLEMENT

Dairy Powder

Effects of dairy control powder

Sponsors & Collaborators

  • Dairy Management Inc.

    collaborator INDUSTRY

  • University of Connecticut

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-20
Primary Completion
2026-05-31
Completion
2026-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05700916 on ClinicalTrials.gov